Release Date: 03/01/17 13:58 Summary: Expiry of Unlisted Options Price Sensitive: No Download Document 33.97KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%